Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States
Sybil Hosek(John H. Stroger, Jr. Hospital of Cook County), Craig M. Wilson(University of Alabama at Birmingham), Kenneth H. Mayer(Centers for Disease Control and Prevention), Jennifer Brothers(John H. Stroger, Jr. Hospital of Cook County), D.R. Harris(Westat (United States)), Raphael J. Landovitz(APLA Health), Gregory D. Zimet(Indiana University – Purdue University Indianapolis), Peter L. Anderson(University of Colorado Denver), Bill G. Kapogiannis(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Kelly Bojan(Ruth M. Rothstein CORE Center), George K. Siberry(National Institutes of Health), Jennifer J. Kiser, Nancy Liu(Westat (United States)), Bret J. Rudy(Columbia University Irving Medical Center), Jim Rooney(Gilead Sciences (United States)), Michelle Lally(Brown University), Brandy Rutledge(Westat (United States)), Kathleen Mulligan(San Francisco General Hospital)
Cited by 226
Related Papers
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|726